Patterns of Antibiotic Nonsusceptibility Among Invasive Group A Streptococcus Infections—United States, 2006–2017

Author:

Fay Katherine1,Onukwube Jennifer1,Chochua Sopio1,Schaffner William2,Cieslak Paul3,Lynfield Ruth4,Muse Alison5,Smelser Chad6,Harrison Lee H7,Farley Monica8,Petit Susan9,Alden Nisha10,Apostal Mirasol11,Snippes Vagnone Paula4,Nanduri Srinivas1,Beall Bernard1,Van Beneden Chris A1

Affiliation:

1. Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. Vanderbilt University School of Medicine, Nashville, Tennessee, USA

3. Public Health Division, Oregon Health Authority, Portland, Oregon, USA

4. Minnesota Department of Health, St Paul, Minnesota, USA

5. Emerging Infections Program, New York State Department of Health, Rochester, New York, USA

6. New Mexico Department of Health, Santa Fe, New Mexico, USA

7. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

8. Emerging Infections Program, Emory University, Atlanta, Georgia, USA

9. Connecticut Department of Public Health, Hartford, Connecticut, USA

10. Colorado Department of Public Health and Environment, Denver, Colorado, USA

11. Emerging Infections Program, Oakland, California, USA

Abstract

Abstract Background Treatment of severe group A Streptococcus (GAS) infections requires timely and appropriate antibiotic therapy. We describe the epidemiology of antimicrobial-resistant invasive GAS (iGAS) infections in the United States (US). Methods We analyzed population-based iGAS surveillance data at 10 US sites from 2006 through 2017. Cases were defined as infection with GAS isolated from normally sterile sites or wounds in patients with necrotizing fasciitis or streptococcal toxic shock syndrome. GAS isolates were emm typed. Antimicrobial susceptibility was determined using broth microdilution or whole genome sequencing. We compared characteristics among patients infected with erythromycin-nonsusceptible (EryNS) and clindamycin-nonsusceptible (CliNS) strains to those with susceptible infections. We analyzed proportions of EryNS and CliNS among isolates by site, year, risk factors, and emm type. Results Overall, 17 179 iGAS cases were reported; 14.5% were EryNS. Among isolates tested for both inducible and constitutive CliNS (2011–2017), 14.6% were CliNS. Most (99.8%) CliNS isolates were EryNS. Resistance was highest in 2017 (EryNS: 22.8%; CliNS: 22.0%). All isolates were susceptible to β-lactams. EryNS and CliNS infections were most frequent among persons aged 18–34 years and in persons residing in long-term care facilities, experiencing homelessness, incarcerated, or who injected drugs. Patterns varied by site. Patients with nonsusceptible infections were significantly less likely to die. The emm types with >30% EryNS or CliNS included types 77, 58, 11, 83, and 92. Conclusions Increasing prevalence of EryNS and CliNS iGAS infections in the US is predominantly due to expansion of several emm types. Clinicians should consider local resistance patterns when treating iGAS infections.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference36 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3